No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Mar 03, 2016

4th Quarter Earnings Call

Feb 22, 2016

24 Month Scleroderma Data

Feb 10, 2016

Source Capital Conference

Jan 12, 2016

Biotech Showcase Presentation

INVESTOR FAQ

Lorem ipsum dolor sit amet, consectetur adipiscing elit?

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit?

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit?

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit?

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo.

Q4 2015 Earnings Release

Q4 2015 Earnings Transcript

Q4 2015 Earnings Webcast

Q4 2015 10-K

Quarterly Reports

  •  
DateFilingDescription 
Apr 06, 2016S-1Securities Registration Statementview PDF
Mar 24, 201610-K/AAmended Annual Reportview PDF
Mar 15, 2016DEF 14AProxy Statement (definitive)view PDF
Mar 15, 2016S-8Securities Registration: Employee Benefit Planview PDF

stock information

screenshot-investors

historical-lookup
AnalystFirm
Keay NakaeAscendiant Capital Markets, LLC
Yale Jen, Ph.D.Laidlaw & Company (UK) Ltd.
Jason KolbertMaxim Group, LLC
Joseph Pantginis, Ph.D.Roth Capital Partners
Henry W. McCuskerScimitar Equity
Dan D. TrangStonegate Securities, Inc.
Stephen G. BrozakWBB Securities, LLC
John M. PutnamWebVest Securities, Inc.

Cytori Therapeutics is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Cytori Therapeutics’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Cytori Therapeutics or its management. Cytori Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Computershare Investor Services

Mailing Addresses

Shareholder correspondence should be mailed to:
Computershare
P.O. BOX 30170
College Station, TX 77842-3170

Overnight correspondence should be sent to:
Computershare
211 Quality Circle, Suite 210
College Station, TX 77845

Shareholder Website

www.computershare.com/investor

Shareholder Online Inquiries

www-us.computershare.com/investor/Contact

management team

board of directors

board committees

Charters

Audit Commitee Charter

Compensation Committee Charter

Governance & Nominating Charter

Committee MemberAuditCompensationGovernance & Nominating
Richard J. Hawkinsmember chair
Paul W. Hawranchair  
Tommy G. Thompsonmemberchair 
Gary A. Lyons membermember
Gail Naughton membermember
chair = Chair   member = Member

Corporate Goverment Materials

Cytori Therapeutics Comprehesive Compliance Program

Code of Business Conduct & Ethics

Ethics Point

Annual Shareholder Meeting

Date: May 10, 2016
Time: 9 AM PST
Location: Cytori Therapeutics, Inc.3020 Callan Rd.San Diego, CA 92121

Record Date: March 11, 2016

Electronic Proxy & Shareholder Material

Cytori Therapeutics is pleased to offer shareholders the option of electronic delivery of its proxy statements and annual 10-K for the 2016 annual meeting. Electronic delivery benefits Cytori and its shareholders through the reduction of printing costs and paper usage, thereby benefiting the environment. We encourage you to enroll.

2013 Annual Report & Proxy Statement

CEO’s Letter to Shareholders

Annual Shareholder Meeting Webcast

Annual Shareholder Meeting Transcript

DEF 14A Proxy Statement (definitive) Nov 24, 2014

RSS feeds

What is RSS?

Really Simple Syndication (RSS) is a technology that allows you to receive updated news from preferred websites, which are sent directly to the user’s news reader. This includes the headlines, summaries and links to the full article on the website.

What are the Benefits of Using RSS?

RSS is an easy way to be notified about updated content on a website. Instead of having to visit a particular website, RSS will automatically send a notification when the subscribed section has been updated.

What Tools Do I Need to Use RSS?

To begin using RSS, a news reader is necessary. There are several desktop applications that can be used, as well as some web based ones. We recommend using Google Reader (www.google. ca/reader) or Bloglines (www.bloglines.com), which can be used through any web browser.

How Can I Sign Up to RSS Feeds?

To subscribe to an RSS feed, select the location of the website of interest and click the small orange button (these buttons usually only exist on the Events, Press Releases, and Presentations) to subscribe to the RSS feed. Next, simply follow the instructions for the particular RSS reader being used.

Email Alerts